至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Biomembrane-inspired lipid nanoparticles enhance CRISPR-Cas9 editing for hemophilia A

Journal of Controlled Release. 2026-10; 
Juan-Juan Zhao, Sai-Ning Tian, Zu-Yi Peng, Jia-Xin Ren, Yang-Yang Zhang, Guo-Hua Li, Dong-Hao Deng, Jian-Ping Zhang, Xiao-Bing Zhang
Products/Services Used Details Operation
Synthetic Guide RNA Chemically synthesized sgRNAs were purchased from GenScript (Nanjing, China). Get A Quote

摘要

Lipid nanoparticles (LNPs) have substantially advanced RNA-based therapies; however, their use for CRISPR-Cas9 remains limited by sub-optimal endosomal escape, innate immune activation, transient nuclease expression, and restricted tissue specificity. Here, we engineered biomembrane-inspired LNPs containing sphingomyelin and C18-galactosyl ceramide (C18-GalCer) to improve liver-targeted CRISPR delivery. The optimized formulation increased in vivo editing efficiency 2.3-fold relative to a benchmark ALC-0315 LNP. Compared with adeno-associated virus (AAV) vectors, transient mRNA delivery reduced the theoretical risk of insertional mutagenesis, lowered innate immune readouts, and allowed dose titration. By pairing... More

关键词

Biomembrane-inspired lipid nanoparticles; C18-galactosyl ceramide (C18-GalCer); CRISPR-Cas9 delivery; Freeze-thaw stability; Hemophilia A; Hepatic RNA delivery; Sphingomyelin.